The impact of duration of treatment on reported time-to-onset in spontaneous reporting systems for pharmacovigilance.
Within pharmacovigilance, knowledge of time-to-onset (time from start of drug administration to onset of reaction) is important in causality assessment of drugs and suspected adverse drug reactions (ADRs) and may indicate pharmacological mechanisms involved. It has been suggested that time-to-onset...
Saved in:
Main Authors: | Ghazaleh Karimi, Kristina Star, G Niklas Norén, Staffan Hägg |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/a5a773b0971f442988c68a22cfee43a7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quality assessment of individual case safety reports in pharmacovigilance in Burkina Faso
by: Roamba Nazaire, et al.
Published: (2021) -
Pharmacovigilance in Covid-19 vaccines
by: Bahouq Hanane, et al.
Published: (2021) -
Pharmacovigilance of quality deviations in the public healthcare system
by: Carolina Resende Bitencourt, et al.
Published: (2019) -
Gathering and exploring scientific knowledge in pharmacovigilance.
by: Pedro Lopes, et al.
Published: (2013) -
A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
by: Bin Wu, et al.
Published: (2021)